Global Cancer Oncology Testing Market Research Report 2025(Status and Outlook)
The market for cancer oncology testing encompasses a wide range of diagnostic and prognostic tools designed to detect, characterize, and monitor cancer through the analysis of biological specimens such as tissue, blood, or other bodily fluids. These tests include molecular diagnostics, genetic sequencing, immunohistochemistry, liquid biopsies, and companion diagnostics, which are used to identify specific biomarkers, mutations, or expression patterns associated with various cancer types. The purpose of these tests is to enable early detection, guide personalized treatment decisions, assess therapy response, monitor disease progression or recurrence, and contribute to research and drug development. Advancements in technologies such as next-generation sequencing (NGS), polymerase chain reaction (PCR), and artificial intelligence (AI) are driving innovation in this field, making testing more precise, accessible, and integrative with clinical workflows. The market is characterized by a growing emphasis on non-invasive methods, the expansion of targeted therapies requiring biomarker identification, and increasing integration of multi-omics data for comprehensive cancer management.
The global Cancer Oncology Testing market size was estimated at USD 2875.6 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 10.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cancer Oncology Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cancer Oncology Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cancer Oncology Testing market.
Global Cancer Oncology Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Market Segmentation (by Type)
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Market Segmentation (by Application)
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cancer Oncology Testing Market
Overview of the regional outlook of the Cancer Oncology Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Oncology Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cancer Oncology Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Cancer Oncology Testing market size was estimated at USD 2875.6 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 10.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cancer Oncology Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cancer Oncology Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cancer Oncology Testing market.
Global Cancer Oncology Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Market Segmentation (by Type)
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Market Segmentation (by Application)
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cancer Oncology Testing Market
Overview of the regional outlook of the Cancer Oncology Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Oncology Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cancer Oncology Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cancer Oncology Testing
1.2 Key Market Segments
1.2.1 Cancer Oncology Testing Segment by Type
1.2.2 Cancer Oncology Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANCER ONCOLOGY TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cancer Oncology Testing Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Cancer Oncology Testing Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANCER ONCOLOGY TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cancer Oncology Testing Product Life Cycle
3.3 Global Cancer Oncology Testing Sales by Manufacturers (2020-2025)
3.4 Global Cancer Oncology Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Cancer Oncology Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cancer Oncology Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cancer Oncology Testing Market Competitive Situation and Trends
3.8.1 Cancer Oncology Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cancer Oncology Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANCER ONCOLOGY TESTING INDUSTRY CHAIN ANALYSIS
4.1 Cancer Oncology Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANCER ONCOLOGY TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cancer Oncology Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cancer Oncology Testing Market
5.7 ESG Ratings of Leading Companies
6 CANCER ONCOLOGY TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Oncology Testing Sales Market Share by Type (2020-2025)
6.3 Global Cancer Oncology Testing Market Size Market Share by Type (2020-2025)
6.4 Global Cancer Oncology Testing Price by Type (2020-2025)
7 CANCER ONCOLOGY TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Oncology Testing Market Sales by Application (2020-2025)
7.3 Global Cancer Oncology Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Cancer Oncology Testing Sales Growth Rate by Application (2020-2025)
8 CANCER ONCOLOGY TESTING MARKET SALES BY REGION
8.1 Global Cancer Oncology Testing Sales by Region
8.1.1 Global Cancer Oncology Testing Sales by Region
8.1.2 Global Cancer Oncology Testing Sales Market Share by Region
8.2 Global Cancer Oncology Testing Market Size by Region
8.2.1 Global Cancer Oncology Testing Market Size by Region
8.2.2 Global Cancer Oncology Testing Market Size Market Share by Region
8.3 North America
8.3.1 North America Cancer Oncology Testing Sales by Country
8.3.2 North America Cancer Oncology Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cancer Oncology Testing Sales by Country
8.4.2 Europe Cancer Oncology Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cancer Oncology Testing Sales by Region
8.5.2 Asia Pacific Cancer Oncology Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cancer Oncology Testing Sales by Country
8.6.2 South America Cancer Oncology Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cancer Oncology Testing Sales by Region
8.7.2 Middle East and Africa Cancer Oncology Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANCER ONCOLOGY TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Cancer Oncology Testing by Region(2020-2025)
9.2 Global Cancer Oncology Testing Revenue Market Share by Region (2020-2025)
9.3 Global Cancer Oncology Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cancer Oncology Testing Production
9.4.1 North America Cancer Oncology Testing Production Growth Rate (2020-2025)
9.4.2 North America Cancer Oncology Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cancer Oncology Testing Production
9.5.1 Europe Cancer Oncology Testing Production Growth Rate (2020-2025)
9.5.2 Europe Cancer Oncology Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cancer Oncology Testing Production (2020-2025)
9.6.1 Japan Cancer Oncology Testing Production Growth Rate (2020-2025)
9.6.2 Japan Cancer Oncology Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cancer Oncology Testing Production (2020-2025)
9.7.1 China Cancer Oncology Testing Production Growth Rate (2020-2025)
9.7.2 China Cancer Oncology Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Devyser
10.1.1 Devyser Basic Information
10.1.2 Devyser Cancer Oncology Testing Product Overview
10.1.3 Devyser Cancer Oncology Testing Product Market Performance
10.1.4 Devyser Business Overview
10.1.5 Devyser SWOT Analysis
10.1.6 Devyser Recent Developments
10.2 Agendia
10.2.1 Agendia Basic Information
10.2.2 Agendia Cancer Oncology Testing Product Overview
10.2.3 Agendia Cancer Oncology Testing Product Market Performance
10.2.4 Agendia Business Overview
10.2.5 Agendia SWOT Analysis
10.2.6 Agendia Recent Developments
10.3 Illumina
10.3.1 Illumina Basic Information
10.3.2 Illumina Cancer Oncology Testing Product Overview
10.3.3 Illumina Cancer Oncology Testing Product Market Performance
10.3.4 Illumina Business Overview
10.3.5 Illumina SWOT Analysis
10.3.6 Illumina Recent Developments
10.4 Personal Genome Diagnostics
10.4.1 Personal Genome Diagnostics Basic Information
10.4.2 Personal Genome Diagnostics Cancer Oncology Testing Product Overview
10.4.3 Personal Genome Diagnostics Cancer Oncology Testing Product Market Performance
10.4.4 Personal Genome Diagnostics Business Overview
10.4.5 Personal Genome Diagnostics Recent Developments
10.5 Veracyte
10.5.1 Veracyte Basic Information
10.5.2 Veracyte Cancer Oncology Testing Product Overview
10.5.3 Veracyte Cancer Oncology Testing Product Market Performance
10.5.4 Veracyte Business Overview
10.5.5 Veracyte Recent Developments
10.6 Pacific Biosciences of California
10.6.1 Pacific Biosciences of California Basic Information
10.6.2 Pacific Biosciences of California Cancer Oncology Testing Product Overview
10.6.3 Pacific Biosciences of California Cancer Oncology Testing Product Market Performance
10.6.4 Pacific Biosciences of California Business Overview
10.6.5 Pacific Biosciences of California Recent Developments
10.7 Qiagen
10.7.1 Qiagen Basic Information
10.7.2 Qiagen Cancer Oncology Testing Product Overview
10.7.3 Qiagen Cancer Oncology Testing Product Market Performance
10.7.4 Qiagen Business Overview
10.7.5 Qiagen Recent Developments
10.8 Agilent Technologies
10.8.1 Agilent Technologies Basic Information
10.8.2 Agilent Technologies Cancer Oncology Testing Product Overview
10.8.3 Agilent Technologies Cancer Oncology Testing Product Market Performance
10.8.4 Agilent Technologies Business Overview
10.8.5 Agilent Technologies Recent Developments
10.9 Natera
10.9.1 Natera Basic Information
10.9.2 Natera Cancer Oncology Testing Product Overview
10.9.3 Natera Cancer Oncology Testing Product Market Performance
10.9.4 Natera Business Overview
10.9.5 Natera Recent Developments
10.10 Bio Rad Laboratories
10.10.1 Bio Rad Laboratories Basic Information
10.10.2 Bio Rad Laboratories Cancer Oncology Testing Product Overview
10.10.3 Bio Rad Laboratories Cancer Oncology Testing Product Market Performance
10.10.4 Bio Rad Laboratories Business Overview
10.10.5 Bio Rad Laboratories Recent Developments
10.11 Myriad Genetics
10.11.1 Myriad Genetics Basic Information
10.11.2 Myriad Genetics Cancer Oncology Testing Product Overview
10.11.3 Myriad Genetics Cancer Oncology Testing Product Market Performance
10.11.4 Myriad Genetics Business Overview
10.11.5 Myriad Genetics Recent Developments
11 CANCER ONCOLOGY TESTING MARKET FORECAST BY REGION
11.1 Global Cancer Oncology Testing Market Size Forecast
11.2 Global Cancer Oncology Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cancer Oncology Testing Market Size Forecast by Country
11.2.3 Asia Pacific Cancer Oncology Testing Market Size Forecast by Region
11.2.4 South America Cancer Oncology Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cancer Oncology Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Cancer Oncology Testing Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Cancer Oncology Testing by Type (2026-2033)
12.1.2 Global Cancer Oncology Testing Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Cancer Oncology Testing by Type (2026-2033)
12.2 Global Cancer Oncology Testing Market Forecast by Application (2026-2033)
12.2.1 Global Cancer Oncology Testing Sales (K Units) Forecast by Application
12.2.2 Global Cancer Oncology Testing Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cancer Oncology Testing
1.2 Key Market Segments
1.2.1 Cancer Oncology Testing Segment by Type
1.2.2 Cancer Oncology Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANCER ONCOLOGY TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cancer Oncology Testing Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Cancer Oncology Testing Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANCER ONCOLOGY TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cancer Oncology Testing Product Life Cycle
3.3 Global Cancer Oncology Testing Sales by Manufacturers (2020-2025)
3.4 Global Cancer Oncology Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Cancer Oncology Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cancer Oncology Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cancer Oncology Testing Market Competitive Situation and Trends
3.8.1 Cancer Oncology Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cancer Oncology Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANCER ONCOLOGY TESTING INDUSTRY CHAIN ANALYSIS
4.1 Cancer Oncology Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANCER ONCOLOGY TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cancer Oncology Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cancer Oncology Testing Market
5.7 ESG Ratings of Leading Companies
6 CANCER ONCOLOGY TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Oncology Testing Sales Market Share by Type (2020-2025)
6.3 Global Cancer Oncology Testing Market Size Market Share by Type (2020-2025)
6.4 Global Cancer Oncology Testing Price by Type (2020-2025)
7 CANCER ONCOLOGY TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Oncology Testing Market Sales by Application (2020-2025)
7.3 Global Cancer Oncology Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Cancer Oncology Testing Sales Growth Rate by Application (2020-2025)
8 CANCER ONCOLOGY TESTING MARKET SALES BY REGION
8.1 Global Cancer Oncology Testing Sales by Region
8.1.1 Global Cancer Oncology Testing Sales by Region
8.1.2 Global Cancer Oncology Testing Sales Market Share by Region
8.2 Global Cancer Oncology Testing Market Size by Region
8.2.1 Global Cancer Oncology Testing Market Size by Region
8.2.2 Global Cancer Oncology Testing Market Size Market Share by Region
8.3 North America
8.3.1 North America Cancer Oncology Testing Sales by Country
8.3.2 North America Cancer Oncology Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cancer Oncology Testing Sales by Country
8.4.2 Europe Cancer Oncology Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cancer Oncology Testing Sales by Region
8.5.2 Asia Pacific Cancer Oncology Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cancer Oncology Testing Sales by Country
8.6.2 South America Cancer Oncology Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cancer Oncology Testing Sales by Region
8.7.2 Middle East and Africa Cancer Oncology Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANCER ONCOLOGY TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Cancer Oncology Testing by Region(2020-2025)
9.2 Global Cancer Oncology Testing Revenue Market Share by Region (2020-2025)
9.3 Global Cancer Oncology Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cancer Oncology Testing Production
9.4.1 North America Cancer Oncology Testing Production Growth Rate (2020-2025)
9.4.2 North America Cancer Oncology Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cancer Oncology Testing Production
9.5.1 Europe Cancer Oncology Testing Production Growth Rate (2020-2025)
9.5.2 Europe Cancer Oncology Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cancer Oncology Testing Production (2020-2025)
9.6.1 Japan Cancer Oncology Testing Production Growth Rate (2020-2025)
9.6.2 Japan Cancer Oncology Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cancer Oncology Testing Production (2020-2025)
9.7.1 China Cancer Oncology Testing Production Growth Rate (2020-2025)
9.7.2 China Cancer Oncology Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Devyser
10.1.1 Devyser Basic Information
10.1.2 Devyser Cancer Oncology Testing Product Overview
10.1.3 Devyser Cancer Oncology Testing Product Market Performance
10.1.4 Devyser Business Overview
10.1.5 Devyser SWOT Analysis
10.1.6 Devyser Recent Developments
10.2 Agendia
10.2.1 Agendia Basic Information
10.2.2 Agendia Cancer Oncology Testing Product Overview
10.2.3 Agendia Cancer Oncology Testing Product Market Performance
10.2.4 Agendia Business Overview
10.2.5 Agendia SWOT Analysis
10.2.6 Agendia Recent Developments
10.3 Illumina
10.3.1 Illumina Basic Information
10.3.2 Illumina Cancer Oncology Testing Product Overview
10.3.3 Illumina Cancer Oncology Testing Product Market Performance
10.3.4 Illumina Business Overview
10.3.5 Illumina SWOT Analysis
10.3.6 Illumina Recent Developments
10.4 Personal Genome Diagnostics
10.4.1 Personal Genome Diagnostics Basic Information
10.4.2 Personal Genome Diagnostics Cancer Oncology Testing Product Overview
10.4.3 Personal Genome Diagnostics Cancer Oncology Testing Product Market Performance
10.4.4 Personal Genome Diagnostics Business Overview
10.4.5 Personal Genome Diagnostics Recent Developments
10.5 Veracyte
10.5.1 Veracyte Basic Information
10.5.2 Veracyte Cancer Oncology Testing Product Overview
10.5.3 Veracyte Cancer Oncology Testing Product Market Performance
10.5.4 Veracyte Business Overview
10.5.5 Veracyte Recent Developments
10.6 Pacific Biosciences of California
10.6.1 Pacific Biosciences of California Basic Information
10.6.2 Pacific Biosciences of California Cancer Oncology Testing Product Overview
10.6.3 Pacific Biosciences of California Cancer Oncology Testing Product Market Performance
10.6.4 Pacific Biosciences of California Business Overview
10.6.5 Pacific Biosciences of California Recent Developments
10.7 Qiagen
10.7.1 Qiagen Basic Information
10.7.2 Qiagen Cancer Oncology Testing Product Overview
10.7.3 Qiagen Cancer Oncology Testing Product Market Performance
10.7.4 Qiagen Business Overview
10.7.5 Qiagen Recent Developments
10.8 Agilent Technologies
10.8.1 Agilent Technologies Basic Information
10.8.2 Agilent Technologies Cancer Oncology Testing Product Overview
10.8.3 Agilent Technologies Cancer Oncology Testing Product Market Performance
10.8.4 Agilent Technologies Business Overview
10.8.5 Agilent Technologies Recent Developments
10.9 Natera
10.9.1 Natera Basic Information
10.9.2 Natera Cancer Oncology Testing Product Overview
10.9.3 Natera Cancer Oncology Testing Product Market Performance
10.9.4 Natera Business Overview
10.9.5 Natera Recent Developments
10.10 Bio Rad Laboratories
10.10.1 Bio Rad Laboratories Basic Information
10.10.2 Bio Rad Laboratories Cancer Oncology Testing Product Overview
10.10.3 Bio Rad Laboratories Cancer Oncology Testing Product Market Performance
10.10.4 Bio Rad Laboratories Business Overview
10.10.5 Bio Rad Laboratories Recent Developments
10.11 Myriad Genetics
10.11.1 Myriad Genetics Basic Information
10.11.2 Myriad Genetics Cancer Oncology Testing Product Overview
10.11.3 Myriad Genetics Cancer Oncology Testing Product Market Performance
10.11.4 Myriad Genetics Business Overview
10.11.5 Myriad Genetics Recent Developments
11 CANCER ONCOLOGY TESTING MARKET FORECAST BY REGION
11.1 Global Cancer Oncology Testing Market Size Forecast
11.2 Global Cancer Oncology Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cancer Oncology Testing Market Size Forecast by Country
11.2.3 Asia Pacific Cancer Oncology Testing Market Size Forecast by Region
11.2.4 South America Cancer Oncology Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cancer Oncology Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Cancer Oncology Testing Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Cancer Oncology Testing by Type (2026-2033)
12.1.2 Global Cancer Oncology Testing Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Cancer Oncology Testing by Type (2026-2033)
12.2 Global Cancer Oncology Testing Market Forecast by Application (2026-2033)
12.2.1 Global Cancer Oncology Testing Sales (K Units) Forecast by Application
12.2.2 Global Cancer Oncology Testing Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cancer Oncology Testing Market Size Comparison by Region (M USD)
Table 5. Global Cancer Oncology Testing Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Cancer Oncology Testing Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Cancer Oncology Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Cancer Oncology Testing Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Oncology Testing as of 2024)
Table 10. Global Market Cancer Oncology Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Cancer Oncology Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Cancer Oncology Testing Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Cancer Oncology Testing Sales by Type (K Units)
Table 26. Global Cancer Oncology Testing Market Size by Type (M USD)
Table 27. Global Cancer Oncology Testing Sales (K Units) by Type (2020-2025)
Table 28. Global Cancer Oncology Testing Sales Market Share by Type (2020-2025)
Table 29. Global Cancer Oncology Testing Market Size (M USD) by Type (2020-2025)
Table 30. Global Cancer Oncology Testing Market Size Share by Type (2020-2025)
Table 31. Global Cancer Oncology Testing Price (USD/Unit) by Type (2020-2025)
Table 32. Global Cancer Oncology Testing Sales (K Units) by Application
Table 33. Global Cancer Oncology Testing Market Size by Application
Table 34. Global Cancer Oncology Testing Sales by Application (2020-2025) & (K Units)
Table 35. Global Cancer Oncology Testing Sales Market Share by Application (2020-2025)
Table 36. Global Cancer Oncology Testing Market Size by Application (2020-2025) & (M USD)
Table 37. Global Cancer Oncology Testing Market Share by Application (2020-2025)
Table 38. Global Cancer Oncology Testing Sales Growth Rate by Application (2020-2025)
Table 39. Global Cancer Oncology Testing Sales by Region (2020-2025) & (K Units)
Table 40. Global Cancer Oncology Testing Sales Market Share by Region (2020-2025)
Table 41. Global Cancer Oncology Testing Market Size by Region (2020-2025) & (M USD)
Table 42. Global Cancer Oncology Testing Market Size Market Share by Region (2020-2025)
Table 43. North America Cancer Oncology Testing Sales by Country (2020-2025) & (K Units)
Table 44. North America Cancer Oncology Testing Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Cancer Oncology Testing Sales by Country (2020-2025) & (K Units)
Table 46. Europe Cancer Oncology Testing Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Cancer Oncology Testing Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Cancer Oncology Testing Market Size by Region (2020-2025) & (M USD)
Table 49. South America Cancer Oncology Testing Sales by Country (2020-2025) & (K Units)
Table 50. South America Cancer Oncology Testing Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Cancer Oncology Testing Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Cancer Oncology Testing Market Size by Region (2020-2025) & (M USD)
Table 53. Global Cancer Oncology Testing Production (K Units) by Region(2020-2025)
Table 54. Global Cancer Oncology Testing Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Cancer Oncology Testing Revenue Market Share by Region (2020-2025)
Table 56. Global Cancer Oncology Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Cancer Oncology Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Cancer Oncology Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Cancer Oncology Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Cancer Oncology Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Devyser Basic Information
Table 62. Devyser Cancer Oncology Testing Product Overview
Table 63. Devyser Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Devyser Business Overview
Table 65. Devyser SWOT Analysis
Table 66. Devyser Recent Developments
Table 67. Agendia Basic Information
Table 68. Agendia Cancer Oncology Testing Product Overview
Table 69. Agendia Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Agendia Business Overview
Table 71. Agendia SWOT Analysis
Table 72. Agendia Recent Developments
Table 73. Illumina Basic Information
Table 74. Illumina Cancer Oncology Testing Product Overview
Table 75. Illumina Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Illumina Business Overview
Table 77. Illumina SWOT Analysis
Table 78. Illumina Recent Developments
Table 79. Personal Genome Diagnostics Basic Information
Table 80. Personal Genome Diagnostics Cancer Oncology Testing Product Overview
Table 81. Personal Genome Diagnostics Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Personal Genome Diagnostics Business Overview
Table 83. Personal Genome Diagnostics Recent Developments
Table 84. Veracyte Basic Information
Table 85. Veracyte Cancer Oncology Testing Product Overview
Table 86. Veracyte Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Veracyte Business Overview
Table 88. Veracyte Recent Developments
Table 89. Pacific Biosciences of California Basic Information
Table 90. Pacific Biosciences of California Cancer Oncology Testing Product Overview
Table 91. Pacific Biosciences of California Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Pacific Biosciences of California Business Overview
Table 93. Pacific Biosciences of California Recent Developments
Table 94. Qiagen Basic Information
Table 95. Qiagen Cancer Oncology Testing Product Overview
Table 96. Qiagen Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Qiagen Business Overview
Table 98. Qiagen Recent Developments
Table 99. Agilent Technologies Basic Information
Table 100. Agilent Technologies Cancer Oncology Testing Product Overview
Table 101. Agilent Technologies Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Agilent Technologies Business Overview
Table 103. Agilent Technologies Recent Developments
Table 104. Natera Basic Information
Table 105. Natera Cancer Oncology Testing Product Overview
Table 106. Natera Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Natera Business Overview
Table 108. Natera Recent Developments
Table 109. Bio Rad Laboratories Basic Information
Table 110. Bio Rad Laboratories Cancer Oncology Testing Product Overview
Table 111. Bio Rad Laboratories Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Bio Rad Laboratories Business Overview
Table 113. Bio Rad Laboratories Recent Developments
Table 114. Myriad Genetics Basic Information
Table 115. Myriad Genetics Cancer Oncology Testing Product Overview
Table 116. Myriad Genetics Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Myriad Genetics Business Overview
Table 118. Myriad Genetics Recent Developments
Table 119. Global Cancer Oncology Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 120. Global Cancer Oncology Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 121. North America Cancer Oncology Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 122. North America Cancer Oncology Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 123. Europe Cancer Oncology Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 124. Europe Cancer Oncology Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 125. Asia Pacific Cancer Oncology Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 126. Asia Pacific Cancer Oncology Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 127. South America Cancer Oncology Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 128. South America Cancer Oncology Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 129. Middle East and Africa Cancer Oncology Testing Sales Forecast by Country (2026-2033) & (Units)
Table 130. Middle East and Africa Cancer Oncology Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 131. Global Cancer Oncology Testing Sales Forecast by Type (2026-2033) & (K Units)
Table 132. Global Cancer Oncology Testing Market Size Forecast by Type (2026-2033) & (M USD)
Table 133. Global Cancer Oncology Testing Price Forecast by Type (2026-2033) & (USD/Unit)
Table 134. Global Cancer Oncology Testing Sales (K Units) Forecast by Application (2026-2033)
Table 135. Global Cancer Oncology Testing Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cancer Oncology Testing Market Size Comparison by Region (M USD)
Table 5. Global Cancer Oncology Testing Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Cancer Oncology Testing Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Cancer Oncology Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Cancer Oncology Testing Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Oncology Testing as of 2024)
Table 10. Global Market Cancer Oncology Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Cancer Oncology Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Cancer Oncology Testing Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Cancer Oncology Testing Sales by Type (K Units)
Table 26. Global Cancer Oncology Testing Market Size by Type (M USD)
Table 27. Global Cancer Oncology Testing Sales (K Units) by Type (2020-2025)
Table 28. Global Cancer Oncology Testing Sales Market Share by Type (2020-2025)
Table 29. Global Cancer Oncology Testing Market Size (M USD) by Type (2020-2025)
Table 30. Global Cancer Oncology Testing Market Size Share by Type (2020-2025)
Table 31. Global Cancer Oncology Testing Price (USD/Unit) by Type (2020-2025)
Table 32. Global Cancer Oncology Testing Sales (K Units) by Application
Table 33. Global Cancer Oncology Testing Market Size by Application
Table 34. Global Cancer Oncology Testing Sales by Application (2020-2025) & (K Units)
Table 35. Global Cancer Oncology Testing Sales Market Share by Application (2020-2025)
Table 36. Global Cancer Oncology Testing Market Size by Application (2020-2025) & (M USD)
Table 37. Global Cancer Oncology Testing Market Share by Application (2020-2025)
Table 38. Global Cancer Oncology Testing Sales Growth Rate by Application (2020-2025)
Table 39. Global Cancer Oncology Testing Sales by Region (2020-2025) & (K Units)
Table 40. Global Cancer Oncology Testing Sales Market Share by Region (2020-2025)
Table 41. Global Cancer Oncology Testing Market Size by Region (2020-2025) & (M USD)
Table 42. Global Cancer Oncology Testing Market Size Market Share by Region (2020-2025)
Table 43. North America Cancer Oncology Testing Sales by Country (2020-2025) & (K Units)
Table 44. North America Cancer Oncology Testing Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Cancer Oncology Testing Sales by Country (2020-2025) & (K Units)
Table 46. Europe Cancer Oncology Testing Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Cancer Oncology Testing Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Cancer Oncology Testing Market Size by Region (2020-2025) & (M USD)
Table 49. South America Cancer Oncology Testing Sales by Country (2020-2025) & (K Units)
Table 50. South America Cancer Oncology Testing Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Cancer Oncology Testing Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Cancer Oncology Testing Market Size by Region (2020-2025) & (M USD)
Table 53. Global Cancer Oncology Testing Production (K Units) by Region(2020-2025)
Table 54. Global Cancer Oncology Testing Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Cancer Oncology Testing Revenue Market Share by Region (2020-2025)
Table 56. Global Cancer Oncology Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Cancer Oncology Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Cancer Oncology Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Cancer Oncology Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Cancer Oncology Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Devyser Basic Information
Table 62. Devyser Cancer Oncology Testing Product Overview
Table 63. Devyser Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Devyser Business Overview
Table 65. Devyser SWOT Analysis
Table 66. Devyser Recent Developments
Table 67. Agendia Basic Information
Table 68. Agendia Cancer Oncology Testing Product Overview
Table 69. Agendia Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Agendia Business Overview
Table 71. Agendia SWOT Analysis
Table 72. Agendia Recent Developments
Table 73. Illumina Basic Information
Table 74. Illumina Cancer Oncology Testing Product Overview
Table 75. Illumina Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Illumina Business Overview
Table 77. Illumina SWOT Analysis
Table 78. Illumina Recent Developments
Table 79. Personal Genome Diagnostics Basic Information
Table 80. Personal Genome Diagnostics Cancer Oncology Testing Product Overview
Table 81. Personal Genome Diagnostics Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Personal Genome Diagnostics Business Overview
Table 83. Personal Genome Diagnostics Recent Developments
Table 84. Veracyte Basic Information
Table 85. Veracyte Cancer Oncology Testing Product Overview
Table 86. Veracyte Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Veracyte Business Overview
Table 88. Veracyte Recent Developments
Table 89. Pacific Biosciences of California Basic Information
Table 90. Pacific Biosciences of California Cancer Oncology Testing Product Overview
Table 91. Pacific Biosciences of California Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Pacific Biosciences of California Business Overview
Table 93. Pacific Biosciences of California Recent Developments
Table 94. Qiagen Basic Information
Table 95. Qiagen Cancer Oncology Testing Product Overview
Table 96. Qiagen Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Qiagen Business Overview
Table 98. Qiagen Recent Developments
Table 99. Agilent Technologies Basic Information
Table 100. Agilent Technologies Cancer Oncology Testing Product Overview
Table 101. Agilent Technologies Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Agilent Technologies Business Overview
Table 103. Agilent Technologies Recent Developments
Table 104. Natera Basic Information
Table 105. Natera Cancer Oncology Testing Product Overview
Table 106. Natera Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Natera Business Overview
Table 108. Natera Recent Developments
Table 109. Bio Rad Laboratories Basic Information
Table 110. Bio Rad Laboratories Cancer Oncology Testing Product Overview
Table 111. Bio Rad Laboratories Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Bio Rad Laboratories Business Overview
Table 113. Bio Rad Laboratories Recent Developments
Table 114. Myriad Genetics Basic Information
Table 115. Myriad Genetics Cancer Oncology Testing Product Overview
Table 116. Myriad Genetics Cancer Oncology Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Myriad Genetics Business Overview
Table 118. Myriad Genetics Recent Developments
Table 119. Global Cancer Oncology Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 120. Global Cancer Oncology Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 121. North America Cancer Oncology Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 122. North America Cancer Oncology Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 123. Europe Cancer Oncology Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 124. Europe Cancer Oncology Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 125. Asia Pacific Cancer Oncology Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 126. Asia Pacific Cancer Oncology Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 127. South America Cancer Oncology Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 128. South America Cancer Oncology Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 129. Middle East and Africa Cancer Oncology Testing Sales Forecast by Country (2026-2033) & (Units)
Table 130. Middle East and Africa Cancer Oncology Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 131. Global Cancer Oncology Testing Sales Forecast by Type (2026-2033) & (K Units)
Table 132. Global Cancer Oncology Testing Market Size Forecast by Type (2026-2033) & (M USD)
Table 133. Global Cancer Oncology Testing Price Forecast by Type (2026-2033) & (USD/Unit)
Table 134. Global Cancer Oncology Testing Sales (K Units) Forecast by Application (2026-2033)
Table 135. Global Cancer Oncology Testing Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cancer Oncology Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Oncology Testing Market Size (M USD), 2024-2033
Figure 5. Global Cancer Oncology Testing Market Size (M USD) (2020-2033)
Figure 6. Global Cancer Oncology Testing Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cancer Oncology Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cancer Oncology Testing Product Life Cycle
Figure 13. Cancer Oncology Testing Sales Share by Manufacturers in 2024
Figure 14. Global Cancer Oncology Testing Revenue Share by Manufacturers in 2024
Figure 15. Cancer Oncology Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Cancer Oncology Testing Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cancer Oncology Testing Revenue in 2024
Figure 18. Industry Chain Map of Cancer Oncology Testing
Figure 19. Global Cancer Oncology Testing Market PEST Analysis
Figure 20. Global Cancer Oncology Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cancer Oncology Testing Market Share by Type
Figure 27. Sales Market Share of Cancer Oncology Testing by Type (2020-2025)
Figure 28. Sales Market Share of Cancer Oncology Testing by Type in 2024
Figure 29. Market Size Share of Cancer Oncology Testing by Type (2020-2025)
Figure 30. Market Size Share of Cancer Oncology Testing by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cancer Oncology Testing Market Share by Application
Figure 33. Global Cancer Oncology Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Cancer Oncology Testing Sales Market Share by Application in 2024
Figure 35. Global Cancer Oncology Testing Market Share by Application (2020-2025)
Figure 36. Global Cancer Oncology Testing Market Share by Application in 2024
Figure 37. Global Cancer Oncology Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cancer Oncology Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Cancer Oncology Testing Market Size Market Share by Region (2020-2025)
Figure 40. North America Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cancer Oncology Testing Sales Market Share by Country in 2024
Figure 43. North America Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cancer Oncology Testing Market Size Market Share by Country in 2024
Figure 45. U.S. Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cancer Oncology Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cancer Oncology Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cancer Oncology Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cancer Oncology Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cancer Oncology Testing Sales Market Share by Country in 2024
Figure 53. Europe Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cancer Oncology Testing Market Size Market Share by Country in 2024
Figure 55. Germany Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cancer Oncology Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cancer Oncology Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cancer Oncology Testing Market Size Market Share by Region in 2024
Figure 68. China Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cancer Oncology Testing Sales and Growth Rate (K Units)
Figure 79. South America Cancer Oncology Testing Sales Market Share by Country in 2024
Figure 80. South America Cancer Oncology Testing Market Size and Growth Rate (M USD)
Figure 81. South America Cancer Oncology Testing Market Size Market Share by Country in 2024
Figure 82. Brazil Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cancer Oncology Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cancer Oncology Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cancer Oncology Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cancer Oncology Testing Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cancer Oncology Testing Production Market Share by Region (2020-2025)
Figure 103. North America Cancer Oncology Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cancer Oncology Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cancer Oncology Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cancer Oncology Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cancer Oncology Testing Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Cancer Oncology Testing Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Cancer Oncology Testing Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Cancer Oncology Testing Market Share Forecast by Type (2026-2033)
Figure 111. Global Cancer Oncology Testing Sales Forecast by Application (2026-2033)
Figure 112. Global Cancer Oncology Testing Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Cancer Oncology Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Oncology Testing Market Size (M USD), 2024-2033
Figure 5. Global Cancer Oncology Testing Market Size (M USD) (2020-2033)
Figure 6. Global Cancer Oncology Testing Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cancer Oncology Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cancer Oncology Testing Product Life Cycle
Figure 13. Cancer Oncology Testing Sales Share by Manufacturers in 2024
Figure 14. Global Cancer Oncology Testing Revenue Share by Manufacturers in 2024
Figure 15. Cancer Oncology Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Cancer Oncology Testing Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cancer Oncology Testing Revenue in 2024
Figure 18. Industry Chain Map of Cancer Oncology Testing
Figure 19. Global Cancer Oncology Testing Market PEST Analysis
Figure 20. Global Cancer Oncology Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cancer Oncology Testing Market Share by Type
Figure 27. Sales Market Share of Cancer Oncology Testing by Type (2020-2025)
Figure 28. Sales Market Share of Cancer Oncology Testing by Type in 2024
Figure 29. Market Size Share of Cancer Oncology Testing by Type (2020-2025)
Figure 30. Market Size Share of Cancer Oncology Testing by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cancer Oncology Testing Market Share by Application
Figure 33. Global Cancer Oncology Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Cancer Oncology Testing Sales Market Share by Application in 2024
Figure 35. Global Cancer Oncology Testing Market Share by Application (2020-2025)
Figure 36. Global Cancer Oncology Testing Market Share by Application in 2024
Figure 37. Global Cancer Oncology Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cancer Oncology Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Cancer Oncology Testing Market Size Market Share by Region (2020-2025)
Figure 40. North America Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cancer Oncology Testing Sales Market Share by Country in 2024
Figure 43. North America Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cancer Oncology Testing Market Size Market Share by Country in 2024
Figure 45. U.S. Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cancer Oncology Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cancer Oncology Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cancer Oncology Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cancer Oncology Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cancer Oncology Testing Sales Market Share by Country in 2024
Figure 53. Europe Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cancer Oncology Testing Market Size Market Share by Country in 2024
Figure 55. Germany Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cancer Oncology Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cancer Oncology Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cancer Oncology Testing Market Size Market Share by Region in 2024
Figure 68. China Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cancer Oncology Testing Sales and Growth Rate (K Units)
Figure 79. South America Cancer Oncology Testing Sales Market Share by Country in 2024
Figure 80. South America Cancer Oncology Testing Market Size and Growth Rate (M USD)
Figure 81. South America Cancer Oncology Testing Market Size Market Share by Country in 2024
Figure 82. Brazil Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cancer Oncology Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cancer Oncology Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cancer Oncology Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cancer Oncology Testing Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cancer Oncology Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cancer Oncology Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cancer Oncology Testing Production Market Share by Region (2020-2025)
Figure 103. North America Cancer Oncology Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cancer Oncology Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cancer Oncology Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cancer Oncology Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cancer Oncology Testing Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Cancer Oncology Testing Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Cancer Oncology Testing Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Cancer Oncology Testing Market Share Forecast by Type (2026-2033)
Figure 111. Global Cancer Oncology Testing Sales Forecast by Application (2026-2033)
Figure 112. Global Cancer Oncology Testing Market Share Forecast by Application (2026-2033)
